SCHEMBL8307017

SCHEMBL8307017

Cc1nc(-c2ccccc2)n(C)c1C=NOCCOC1CCCCO1

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 1/20 0.39
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
ADORA3 P0DMS8 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
P2RX3 P56373 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TGFBR1 P36897 1/20 0.32
TGFBR2 P37173 1/20 0.32
MET P08581 2/20 0.32
MGLL Q99685 1/20 0.32
KDM4E B2RXH2 1/20 0.31
GLA P06280 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3083554 0.77 KDM4C (0.44) KDM4CNPC1RAB9AADORA3MEN1
SCHEMBL3083557 0.77 KDM4C (0.44) KDM4CNPC1RAB9AADORA3MEN1
SCHEMBL8310061 0.76 TARBP2 (0.34) NPC1RAB9AKDM4EMAPT
SCHEMBL8304494 0.74 KDM4C (0.44) KDM4CNPC1RAB9AADORA3MEN1
SCHEMBL8309572 0.74 KDM4C (0.46) KDM4CNPC1RAB9AMEN1KMT2A
SCHEMBL8309057 0.73 KDM4C (0.39) KDM4CNPC1RAB9AADORA3MEN1
SCHEMBL8304360 0.72 KDM4C (0.46) KDM4CNPC1RAB9AMEN1KMT2A
SCHEMBL3076916 0.71 KDM4C (0.50) KDM4CNPC1RAB9AMEN1KMT2A
SCHEMBL3076918 0.71 KDM4C (0.50) KDM4CNPC1RAB9AMEN1KMT2A
SCHEMBL8307843 0.70 KDM4C (0.52) KDM4CNPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed